Solid Biosciences

Letter to the Duchenne Community

Dear Duchenne Community, As we come together for the annual Parent Project Muscular Dystrophy (PPMD) conference over the next several days, we want to begin by recognizing the strength, resilience and partnership of this community. We are grateful for the opportunity to connect with so many…

Letter to the FA Community

Dear Friedreich’s ataxia (FA) community,  As we begin the new year, we want to wish you and your families a happy and healthy 2026 and thank the FA community for your trust and partnership. We are writing to share an important update on FALCON, our first-in-human clinical study…

Letter to the CPVT Community

Dear CPVT Community, We are pleased to introduce Solid Biosciences to the CPVT community—and to share important news about our investigational gene therapy, SGT-501. Patient-focused and founded by individuals directly impacted by Duchenne muscular dystrophy, Solid’s mission is to improve the daily…

Letter to the Duchenne Community – INSPIRE DUCHENNE Positive Initial Clinical Trial Data

Letter to the Duchenne Community: With heartfelt gratitude, I want to begin by thanking the patients and families participating in the INSPIRE DUCHENNE clinical study – you are the true heroes of this journey. Your bravery and commitment are what drive our work as we strive to advance a more…